Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Comment by McLachertyon Nov 11, 2010 9:03am
133 Views
Post# 17691395

RE: Insider

RE: Insider This is what we have been talking about plus the shares sold by a couple of management staff. I still have to believe that if negotiations are in swing they would not be allowed to take options as they would be part of deal. Just an opinion. ----------Original Message Posted 11/11/2010 8:32:10 AM----------

Halo Resources Ltd. (HLO)

As of November 10th, 2010
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Nov 10/10 Nov 06/10 Joe Dwek Management Consultants 2007 Inc. Control or Direction Warrants 55 - Expiration of warrants -43,730  
Nov 10/10 Nov 06/10 Joe Dwek Management Consultants 2007 Inc. Control or Direction Options 52 - Expiration of options -174,921  
Nov 10/10 Sep 03/10 Joe Dwek Management Consultants 2007 Inc. Control or Direction Options 37 - Stock split or consolidation -2,487,793  
Nov 10/10 Sep 03/10 Joe Dwek Management Consultants 2007 Inc. Control or Direction Warrants 37 - Stock split or consolidation -393,573  
Nov 09/10 Nov 06/10 Joe Dwek Management Consultants 2007 Inc. Control or Direction Warrants 55 - Expiration of warrants -874,607
<< Previous
Bullboard Posts
Next >>